Thymosin fraction 5 inhibits the proliferation of the rat neuroendocrine MMQ pituitary adenoma and C6 glioma cell lines in vitro

Endocrinology
B L SpangeloM Badamchian

Abstract

Cytokines such as interleukin-1 (IL-1) and IL-6 stimulate the hypothalamic-pituitary-adrenal (HPA) axis. In addition, these proteins affect pituitary cell proliferation in vitro. Thymosin fraction 5 (TF5) is a partially purified preparation of the bovine thymus that enhances immune system functioning. Because TF5 similarly stimulates the HPA axis, we examined the effects of this preparation on neuroendocrine tumor cell proliferation. Cells of the PRL-secreting rat anterior pituitary adenoma, MMQ (5-50 x 10(3) cells/well), were exposed to vehicle (RPMI-1640 containing 2.5% FCS, 7.5% horse serum, and antibiotics) or TF5 (100-500 microg/ml) for up to 96 h and the proliferation of MMQ cells monitored using the MTT assay (3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide). TF5-mediated inhibition of cell proliferation was dependent on both TF5 concentration and the initial MMQ cell number. Minimal reductions in optical densities resulted from exposure to 100 microg/ml TF5, whereas the highest concentration of this preparation (i.e. 500 microg/ml) completely blocked MMQ cell division. The concentration-dependent effects of TF5 were particularly striking at initial plating densities of 25 and 50 x 10(3) MMQ cells/well; in...Continue Reading

References

Jan 1, 1992·Neuroendocrinology·L Milenkovic, S M McCann
Nov 1, 1992·Neuroendocrinology·L MilenkovicS M McCann
Apr 1, 1992·International Journal of Immunopharmacology·J W Hadden
Feb 1, 1992·Clinical and Experimental Immunology·S IkemotoM Maekawa
Jan 1, 1989·International Journal of Immunopharmacology·C FavalliE Garaci
Sep 1, 1988·Immunopharmacology·N M KouttabA L Maizel
Jan 1, 1987·Annals of the New York Academy of Sciences·B L SpangeloA L Goldstein
Jul 26, 1968·Science·P BendaW Sweet
Oct 1, 1995·The Journal of Endocrinology·B L Spangelo
Feb 1, 1995·Journal of Endocrinological Investigation·T SawadaA Miyake
Jan 1, 1995·Frontiers in Neuroendocrinology·B L Spangelo, W C Gorospe
Jun 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·L A Caron-LeslieJ A Cidlowski
Jun 1, 1993·Neuroendocrinology·C V AlvarezF Dominguez
Sep 1, 1993·Immunopharmacology·W Y AttiaB L Spangelo
Sep 1, 1993·Journal of Neuroimmunology·E G GutierrezA J Kastin
Sep 1, 1995·Neuroimmunomodulation·B L SpangeloW C Gorospe

❮ Previous
Next ❯

Citations

Jan 30, 2010·Journal of Oncology·Arno SungarianSuzanne M de la Monte
Dec 1, 2001·Expert Opinion on Biological Therapy·B Bodey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.